BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32988596)

  • 41. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term prognosis and quality of life of survivors with hepatitis B virus-related acute-on-chronic liver failure].
    Zhu CY; Lu GT; Qi TT; He QJ; Chen YP; Wen WQ; Zhou FY; Chen JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):736-741. PubMed ID: 29997098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma cell-free DNA for predicting outcomes of patients with HBV-related acute-on-chronic liver failure: a pilot study.
    Li F; Yan T; Li K; Mu J; Su H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):147-52. PubMed ID: 24589586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure.
    Zhou C; Zhang N; He TT; Wang Y; Wang LF; Sun YQ; Jing J; Zhang JJ; Fu SN; Wang X; Liang XX; Li X; Gong M; Li J
    World J Gastroenterol; 2020 Aug; 26(30):4479-4488. PubMed ID: 32874059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.
    Sun Z; Liu X; Wu D; Gao H; Jiang J; Yang Y; Wu J; Gao Q; Wang J; Jiang Z; Xu Y; Xu X; Li L
    Theranostics; 2019; 9(4):1200-1214. PubMed ID: 30867825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure.
    Wu Y; You S; Zang H; Liu H; Mao Y; Mao P; Zhu B; Xu J; Xie G; Guo J; Li D; Xin S; Wan Z
    Ann Hepatol; 2015; 14(2):218-24. PubMed ID: 25671831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Tong JJ; Zhao W; Mu XY; Xu X; Su HB; Liu XY; Chen J; Zhai XR; Wang Y; Hu JH
    Chin Med J (Engl); 2019 Jul; 132(13):1541-1549. PubMed ID: 31188162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive value of low interleukin-33 in critically ill patients.
    Krychtiuk KA; Stojkovic S; Lenz M; Brekalo M; Huber K; Wojta J; Heinz G; Demyanets S; Speidl WS
    Cytokine; 2018 Mar; 103():109-113. PubMed ID: 28974430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.
    Gao FY; Liu Y; Li XS; Ye XQ; Sun L; Geng MF; Wang R; Liu HM; Zhou XB; Gu LL; Liu YM; Wan G; Wang XB
    World J Gastroenterol; 2015 Jul; 21(27):8373-81. PubMed ID: 26217089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    Yuan W; Zhang YY; Zhang ZG; Zou Y; Lu HZ; Qian ZP
    Am J Med Sci; 2017 May; 353(5):452-458. PubMed ID: 28502331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
    Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
    J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
    Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
    Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A study on treatment timing selection and short-term efficacy prediction with changes in cytokine levels before and after non-biological artificial liver treatment in acute-on-chronic liver failure].
    An XY; Hu LX; Li M; Liu BC; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1218-1224. PubMed ID: 36891701
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of ST2 and ST2 genetic variants in schistosomiasis.
    Long X; Daya M; Zhao J; Rafaels N; Liang H; Potee J; Campbell M; Zhang B; Araujo MI; Oliveira RR; Mathias RA; Gao L; Ruczinski I; Georas SN; Vercelli D; Beaty TH; Barnes KC; Chen X; Chen Q
    J Allergy Clin Immunol; 2017 Nov; 140(5):1416-1422.e6. PubMed ID: 28189770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.
    Shen J; Shang Q; Wong CK; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Yu SL; Kuan WP; Yu CM; Tam LS
    Semin Arthritis Rheum; 2015 Aug; 45(1):18-27. PubMed ID: 25798875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF.
    Wu ZB; Zheng YB; Wang K; Mo ZS; Zhen X; Yan Y; Gao ZL
    Can J Gastroenterol Hepatol; 2021; 2021():5545181. PubMed ID: 34805027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
    Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
    Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure.
    Liu L; Lan Q; Lin L; Lu J; Ye C; Tao Q; Cui M; Zheng S; Zhang X; Xue Y
    Clin Chim Acta; 2018 Jan; 476():92-97. PubMed ID: 29170103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.